David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CALL
Vale
VALE
$64.5B
| $2.05M | ﹤0.01% |
155,000
| – | – |
|
|
RETA
2402
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.04M | ﹤0.01% |
+10,000
| New | +$1.82M |
|
|
KRTX
2403
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.04M | ﹤0.01% |
+27,118
| New | +$1.19M |
|
|
AMRS
2404
DELISTED
Amyris Inc.
AMRS
| $2.04M | ﹤0.01% |
660,709
+285,644
| +76% | +$1.06M |
|
2405
PUT
Sony
SONY
$141B
| $2.04M | ﹤0.01% |
150,000
| – | – |
|
|
SKX
2406
CALL
DELISTED
Skechers
SKX
| $2.04M | ﹤0.01% |
+47,200
| New | +$1.86M |
|
|
CASA
2407
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $2.03M | ﹤0.01% |
497,377
-80,891
| -14% | -$386K |
|
2408
PUT
Leggett & Platt
LEG
$1.26B
| $2.03M | ﹤0.01% |
+40,000
| New | +$1.96M |
|
2409
PUT
Rockwell Automation
ROK
$47.9B
| $2.03M | ﹤0.01% |
10,000
| – | – |
|
|
CSW
2410
CSW Industrials
CSW
$5.26B
| $2.02M | ﹤0.01% |
26,257
-1,170
| -4% | -$84.1K |
|
2411
CALL
Vornado Realty Trust
VNO
$7.27B
| $2.02M | ﹤0.01% |
30,400
| – | – |
|
2412
UFP Industries
UFPI
$4.76B
| $2.02M | ﹤0.01% |
+42,350
| New | +$2M |
|
|
SNV
2413
CALL
DELISTED
Synovus
SNV
| $2.02M | ﹤0.01% |
51,500
-20,000
| -28% | -$735K |
|
2414
NOV
NOV
$7.21B
| $2.02M | ﹤0.01% |
+80,553
| New | +$1.81M |
|
|
LM
2415
PUT
DELISTED
Legg Mason, Inc.
LM
| $2.02M | ﹤0.01% |
56,200
+2,900
| +5% | +$108K |
|
|
AMWD
2416
CALL
DELISTED
American Woodmark
AMWD
| $2.02M | ﹤0.01% |
+19,300
| New | +$1.94M |
|
2417
Arbor Realty Trust
ABR
$944M
| $2.02M | ﹤0.01% |
140,464
-130,613
| -48% | -$1.86M |
|
2418
PUT
Lands' End
LE
$374M
| $2.02M | ﹤0.01% |
120,000
| – | – |
|
2419
PUT
Verisk Analytics
VRSK
$24.5B
| $2.02M | ﹤0.01% |
+13,500
| New | +$2M |
|
2420
Highwoods Properties
HIW
$3.48B
| $2.01M | ﹤0.01% |
41,187
-227,388
| -85% | -$10.5M |
|
2421
PUT
Trip.com Group
TCOM
$28.4B
| $2.01M | ﹤0.01% |
60,000
| – | – |
|
2422
Opko Health
OPK
$1.13B
| $2.01M | ﹤0.01% |
1,367,150
-831,068
| -38% | -$1.39M |
|
|
VRNT
2423
DELISTED
Verint Systems
VRNT
| $2.01M | ﹤0.01% |
71,261
+52,848
| +287% | +$1.29M |
|
2424
Innospec
IOSP
$2.36B
| $2.01M | ﹤0.01% |
19,410
-7,740
| -29% | -$740K |
|
|
DENN
2425
DELISTED
Denny's
DENN
| $2.01M | ﹤0.01% |
100,914
+10,636
| +12% | +$219K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.